We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Clavis Pharma Announces Results of the LEAP Study of CP-4126 in Metastatic Pancreatic Cancer

News   Nov 19, 2012

 
Clavis Pharma Announces Results of the LEAP Study of CP-4126 in Metastatic Pancreatic Cancer
 
 
 

RELATED ARTICLES

Why Some Cancers Affect Only Young Women

News

UNIGE and HUG scientists show that rare ovarian and pancreatic cancers in young women are caused by cells that have settled in an organ other than the one for which they were intended during embryogenesis.

READ MORE

Fat Fuels Aggressive Brain Cancers

News

Fat is powering tumour growth in brain cancer, finds a new study by Cardiff University and the University of Florida.

READ MORE

Glioblastoma Overcomes Treatment Resistance in Promising Preclinical Study

News

A novel method of overcoming treatment resistance to both PD-1 and adoptive cellular therapy has been identified, by employing a concomitant hematopoietic stem and progenitor cell transfer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE